Pre-Review
The ORC is the administrative office responsible for oversight of the human subjects review process. Within one to two days of submission, the Office of Research Compliance will provide an initial administrative review for completeness. This is completed by the IRB Coordinator and not part of the regulatory review process. Upon receipt of an application, the IRB Coordinator will review the application for signatures, CITI training verification and completion (the application is typed, no sections are missing and all applicable documents, such as consent forms, are attached). If the application is complete, it will be assigned for review. Incomplete or handwritten protocols will be returned to the investigator for resubmission. The IRB Coordinator will also verify the type of review. The IRB Coordinator will contact the Principal and Co- Investigator(s) via phone or email if any additional materials are required.
Exempt Review
Research involving minor children may be exempt only as it applies to categories 1, 4, 5, 6, 7 and 8. Research involving minors which falls under category 2 may be exempt for educational tests and observation (when the investigator does not participate in the activities being observed). Research involving survey or interview procedures may not be exempted for minors. Research activities in which the only involvement of human subjects will be in one or more of the following categories will qualify for an exempt review. Research involving prisoners may not be exempted.
Category 1
Research conducted in established or commonly accepted educational settings that specifically involves normal educational practices and does not impact students’ opportunity to learn the required educational content, or impact the assessment of educators providing the instruction, such as:
- research on regular and special education instructional strategies, or
- research on the effectiveness of or the comparison among instructional techniques, curricula, or classroom management methods.
Category 2
Research on adults involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of public behavior (including visual or auditory recording) uninfluenced by the investigator if:
- information obtained is recorded in such a manner that human subjects cannot be identified, directly or through identifiers linked to the subjects; OR
- any disclosure of the human subjects’ responses outside the research could reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement or reputation; OR
- a Limited IRB Review is done for data that can be linked with identifiers.
Research can be conducted with minors, only if it is limited to educational tests (cognitive, diagnostic, aptitude, achievement) or observation of public behavior where the researcher does NOT participate in the activity observed.
Category 3
Research involving the use of benign behavioral (non-medical) interventions in conjunction with the collection of information from an adult subject. Information obtained must be collected in such a way that:
- the identity of the human subjects cannot readily be ascertained directly or through identifiers; or
- any public disclosure of the responses would not reasonably place the subject at risk of criminal or civil liability, be damaging to the subjects’ financial standing, educational advancement, or reputation; OR
- a Limited IRB Review is conducted for data that can be linked with identifiers.
Category 4
Secondary research for which consent is not required. This can include identifiable private information or identifiable bio-specimens, if at least one of the following conditions are met:
- the identifiable private information or identifiable bio-specimens are publicly available;
- information (including about bio-specimens) is recorded in such a way that the identity of the subjects cannot be readily ascertained directly or through identifiers, and the investigator will not contact subjects or attempt to re-identify subjects;
- the research involves only information collection and analysis involving the investigator’s use of identifiable health information for the purpose of “health care operations”; or
- research is conducted by, or on behalf of, a Federal department or agency using government-generated or government-collected information obtained for non-research purposes if maintained per compliance with section 2(b) of the E-Government Act of 2002.
Category 5
Research and demonstration projects which are conducted by or subject to the approval of department or agency heads, and which are designed to study, evaluate, or otherwise examine at least one of the following:
- public benefit or service programs;
- procedures for obtaining benefits or services under those programs;
- possible changes in or alternatives to those programs or procedures;
- possible changes in methods or levels of payment for benefits or services under those pro
In order fall under category 5, the project must be published on a publicly accessible Federal website prior to commencing the research and conducted pursuant to a specific federal department or agency.
Category 6
Taste and food quality evaluation and consumer acceptance studies:
- if wholesome foods without additives are consumed; or
- if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U. Department of Agriculture.
Category 7
Storage or maintenance of identifiable private information or identifiable bio-specimens for use in secondary research when broad consent has been obtained, appropriately documented, or waived in accordance with the regulations regarding informed consent. If a change is made for research purposes in the way the identifiable private information or identifiable bio-specimens are stored or maintained, adequate provision must be made to protect the privacy of subjects and maintain the confidentiality of the data.
A Limited IRB Review of research conducted under this category is required.
Category 8
Research involving the use of identifiable private information or identifiable bio-specimens for secondary research use can be conducted if broad consent for storage, maintenance, and secondary research use was obtained in accordance with the regulations regarding informed consent, documentation of informed consent is in place, or a waiver of documentation of informed consent was obtained. The investigator cannot include returning individual research results to subjects as part of the study plan, except in cases required by law.
A Limited IRB Review of research conducted under this category is required.
Expedited
Expedited research activities involve no more than “minimal risk” to participants. Expedited review procedures are described in the DHHS regulations at 45 CFR 46.110. The list of categories that may be reviewed by the IRB through an expedited review are listed below:
Category 1
Clinical studies of drugs and medical devices only when condition (a) or (b) is met:
- Research on drugs for which an investigational new drug application (21 CFR Part 312) is not required. (Note: Research on marketed drugs that significantly increases the risks or decreases the acceptability of the risks associated with the use of the product is not eligible for expedited review); or
- Research on medical devices for which (i) an investigational device exemption application (21 CFR Part 812) is not required; or (ii) the medical device cleared/approved for marketing and the medical device is being used in accordance with its cleared/approved labeling.
Category 2
Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows:
- from healthy, non-pregnant adults who weigh at least 110 pound For these participants, the amounts drawn may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or
- from other adults and children considering the age, weight, and health of the participants, the collection procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these participants, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection may not occur more frequently than 2 times per week.
- Prospective collection of biological specimens for research purposes by noninvasive means. Examples include:
- hair and nail clippings in a nondisfiguring manner;
- deciduous teeth at time of exfoliation or if routine patient care indicates a need for extraction;
- permanent teeth if routine patient care indicates a need for extraction;
- excreta and external secretions (including sweat);
- uncannulated saliva collected either in an unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to the tongue;
- placenta removed at delivery;
- amniotic fluid obtained at the time of rupture of the membrane prior to or during labor;
- supra- and subgingival dental plaque and calculus, provided the collection procedure is not more invasive than routine prophylactic scaling of the teeth and the process is accomplished in accordance with accepted prophylactic techniques;
- mucosal and skin cells collected by buccal scraping or swab, skin swab, or mouth washings;
- sputum collected after saline mist nebulization.
Category 4
Collection of data through noninvasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwave Where medical devices are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety and effectiveness of the medical device are not generally eligible for expedited review, including studies of cleared medical devices for new indications.) Examples include:
- physical sensors that are applied either to the surface of the body or at a distance and do not involve input of significant amounts of energy into the subject or an invasion of the subject’s privacy;
- weighing or testing sensory acuity;
- magnetic resonance imaging;
- electrocardiography, electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinography, ultrasound, diagnostic infrared imaging, doppler blood flow, and echocardiography;
- moderate exercise, muscular strength testing where appropriate given the age, weight, and health of the individual.
Category 5
Research involving materials (data, documents, records, or specimens) that have been collected, or will be collected solely for non-research purposes (such as medical treatment or diagnosis).
(NOTE: Some research in this category may be exempt from the U.S. Department of Health and Human Services regulations for the protection of human participants. 45 CFR 46.101(b)(4). This listing refers only to research that is not exempt.)
Category 6
Collection of data from voice, video, digital, or image recordings made for research purposes.
Category 7
Research on individual or group characteristics or behavior (including, but not limited to, research on perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies.
(NOTE: Some research in this category may be exempt from the DHHS regulations for the protection of human participants. 45 CFR 46.101(b)(2) and (b)(3). This listing refers only to research that is not exempt.)
Category 8
Continuing review of research previously approved by the convened IRB as follows:
- where (i) the research is permanently closed to the enrollment of new participants; (ii) all participants have completed all research- related interventions; and (iii) the research remains active only for long-term follow-up participants; or
- where no participants have been enrolled and no additional risks have been identified; or
- where the remaining research activities are limited to data analysis.
Category 9
Continuing review of research, not conducted under an investigational new drug application or investigational device exemption where categories two (2) through eight (8) do not apply but the IRB has determined and documented at a convened meeting that the research involves no greater than minimal risk and no additional risks have been identified.
Full Board
Any research project involving the use of human participants which does not fall into an exempt or expedited review category must be submitted for full board review. Research projects involving more than minimal risk and the use of human participants under the age of 18 years of age or other protected populations may qualify for full board review.
Annual Renewals
The IRB is required to continue to review full board approved research at intervals appropriate to the degree of risk, but not less than within 12 months from the review date. Expedited protocols have a three-year life cycle and can be renewed within those three years. If the research is not complete by the third year a new protocol application must be submitted.
Exempt protocols do not require annual renewal; however they expire after 3 years.
Expirations
All protocols have a 3 year expiration period. Full Board approved protocols require annual renewal during this 3 year period, Expedited protocols will need to have a Status Update form completed.
Modifications
Any modifications to an approved protocol (exempt and non-exempt) must be brought forward to the Office of Research Compliance and the IRB. The IRB Coordinator will review any changes to an exempt protocol, as changes that increase the risk may require the protocol to undergo an expedited or full board review. The IRB will review any changes to non-exempt research after its approval. Again, the review level may vary from the original review depending on the risk level. The approval of the amendment will not extend the continuing approval date, unless the research was originally exempt and is now determined to be non-exempt.